Satogesic Patch
FDA Label NDC 49873-060

4 label sections · Submitted to the FDA by Sato Pharmaceutical Co., Ltd. · Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Sato Pharmaceutical Co., Ltd. for the product Satogesic (NDC 49873-060). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding otc - when using, otc - stop use, other safety information, otc - keep out of reach of children, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Otc - When Using

When using this product

■ avoid contact with the eyes or mucous membranes ■ do not bandage the area

tightly and do not apply local heat (heating pads, lamps, hot water in bags or bottles)

because doing so can increase the risk of serious burns

Otc - Stop Use

Stop use and ask a doctor if

■ condition worsens ■ symptoms persist for more than 7 days ■ symptoms clear up

and occur again within a few days

■ excessive irritation of the skin develops ■ nausea, vomiting,

abdominal discomfort, diarrhea, or skin rash occurs

■ when using for pain of arthritis:

■ pain persists for more than 10 days ■ redness is present ■ in conditions

affecting children under 12 years of age

■ you experience pain, swelling, or blistering of the skin (this product should not cause

pain or skin damage)

Other Safety Information

Warning - Rare cases of serious burns have been reported to occur on the skin where

OTC external analgesics were applied. Read and follow all directions and warnings on

this label.

Otc - Keep Out Of Reach Of Children

Keep out of reach of children to avoid accidental poisoning. If swallowed, get medical

help or contact a Poison Control Center right away.

* Please review the disclaimer below.